APA (7th ed.) Citation

Fu, Y., Yang, R., Su, Y., Ma, R., Wei, T., Yu, Y., . . . Li, Y. (2025). Cisplatin + docetaxel improves survival over cisplatin + mitomycin C in hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: A retrospective study based on propensity score matching. International Journal of Hyperthermia, 42(1), 1. https://doi.org/10.1080/02656736.2025.2467296

Chicago Style (17th ed.) Citation

Fu, Yu-Bin, Rui Yang, Yan-Dong Su, Ru Ma, Tian Wei, Yang Yu, Bing Li, and Yan Li. "Cisplatin + Docetaxel Improves Survival over Cisplatin + Mitomycin C in Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Retrospective Study Based on Propensity Score Matching." International Journal of Hyperthermia 42, no. 1 (2025): 1. https://doi.org/10.1080/02656736.2025.2467296.

MLA (9th ed.) Citation

Fu, Yu-Bin, et al. "Cisplatin + Docetaxel Improves Survival over Cisplatin + Mitomycin C in Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Retrospective Study Based on Propensity Score Matching." International Journal of Hyperthermia, vol. 42, no. 1, 2025, p. 1, https://doi.org/10.1080/02656736.2025.2467296.